TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
1.130
-0.020 (-1.74%)
At close: Dec 8, 2025, 4:00 PM EST
1.150
+0.020 (1.77%)
After-hours: Dec 8, 2025, 6:30 PM EST
TELA Bio Market Cap
TELA Bio has a market cap or net worth of $49.46 million as of December 8, 2025. Its market cap has decreased by -56.70% in one year.
Market Cap
49.46M
Enterprise Value
63.32M
1-Year Change
-56.70%
Ranking
Category
Stock Price
$1.13
Market Cap Chart
Since November 8, 2019, TELA Bio's market cap has decreased from $146.94M to $49.46M, a decrease of -66.34%. That is a compound annual growth rate of -16.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 8, 2025 | 49.46M | -58.42% |
| Dec 31, 2024 | 118.95M | -26.62% |
| Dec 29, 2023 | 162.12M | -26.42% |
| Dec 30, 2022 | 220.33M | 18.68% |
| Dec 31, 2021 | 185.65M | -14.47% |
| Dec 31, 2020 | 217.06M | 46.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 893.23B |
| Johnson & Johnson | 485.76B |
| AbbVie | 394.34B |
| UnitedHealth Group | 293.15B |
| AstraZeneca | 280.30B |
| Novartis AG | 253.21B |
| Merck & Co. | 245.55B |
| Thermo Fisher Scientific | 213.48B |